Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FZ78L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,967
Award facts
- Contract value 100% obligated
- $9,966.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,966.78 to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 15 mg/0.5 mL pen injections on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order represents a transactional purchase under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key provider within the DLA's pharmaceutical procurement infrastructure.
Quick answers
Who was awarded contract SPE2DR26FZ78L?
SPE2DR26FZ78L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FZ78L worth?
The government has obligated $9,967 on SPE2DR26FZ78L.
Is contract SPE2DR26FZ78L an order under another contract?
Yes. SPE2DR26FZ78L is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ78L competed?
The extent of competition for SPE2DR26FZ78L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award